ArticleOncotarget2016

MZF-1/Elk-1 interaction domain as therapeutic target for protein kinase Cα-based triple-negative breast cancer cells.

Chia-Jen Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.